FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938688055> ?p ?o ?g. }

• W2938688055 endingPage "20180893" @default.
• W2938688055 startingPage "20180893" @default.
• W2938688055 abstract "Evaluate the factors associated with pseudoaneurysm development and morphology. Measure ultrasound-guided thrombin injection (UGTI) and surgical treatment outcomes for pseudoaneurysms, and the necessity for post-primary intervention (reintervention).Retrospective analysis of ultrasound scans and CT angiography of peripheral pseudoaneurysm interventions from February 2011 to April 2017. 99 patients (61.6% female) were identified; median age 72 years (range 12-89). Multivariate analysis of patient demographics, including pre-intervention anticoagulant and antiplatelet medication was performed.Primary intervention for peripheral pseudoaneurysms (62.6% common femoral artery) included 93 UGTI and 6 surgical repairs; with 12 reinterventions (9 UGTI and 3 surgical). Pseudoaneurysm incidence for vascular interventional radiology (VIR) was 0.48% (31/6451) and cardiology was 0.24% (60/25,229). Rates for primary success, immediate complications, 30-day mortality and reintervention were measured respectively for UGTI (98.9%, 3.0%, 2.0%, and 11.8%) and surgical repair (100%, 0.0%, 22.2% and 16.7%). Reintervention risk factors included pre-intervention thrombocytopaenia (<150 × 109/L) ( p = 0.025) and pseudoaneurysms following vascular surgery (p = 0.033). Other positive associations for reintervention (non-significant) included use of a sheath size > 6 Fr ( p = 0.108) or arterial closure device ( p = 0.111) during the pseudoaneurysm causative procedure. The pre-intervention warfarin subgroup developed a larger mean pseudoaneurysm sac size (4.21 cm, range 0.9-7.6), compared to no treatment (p = 0.003), aspirin (p = 0.005) and clopidogrel (p = 0.026) subgroups. UGTI dosage for thrombosis had a positive correlation with incremental sac size increase (p < 0.001).The main reintervention risk factor was pre-intervention thrombocytopaenia, with additional positive associations including pseudoaneurysms caused by surgery, increased sheath size and arterial closure devices. Warfarinized patients developed larger sac-sized pseudoaneurysms compared with other pre-intervention regimens, with positive correlation of higher UGTI dosage required for thrombosis.Patients with pre-intervention thrombocytopaenia and pseudoaneurysms attributed to vascular surgery are subgroups that may benefit from post-intervention imaging surveillance due to significant reintervention risk." @default.
• W2938688055 created "2019-04-25" @default.
• W2938688055 creator A5001639498 @default.
• W2938688055 creator A5045497498 @default.
• W2938688055 creator A5048847703 @default.
• W2938688055 creator A5076118084 @default.
• W2938688055 creator A5091357479 @default.
• W2938688055 date "2019-05-15" @default.
• W2938688055 modified "2023-10-18" @default.
• W2938688055 title "Factors associated with pseudoaneurysm development and necessity for reintervention: a single centre study" @default.
• W2938688055 cites W1487233932 @default.
• W2938688055 cites W1547209330 @default.
• W2938688055 cites W1693654236 @default.
• W2938688055 cites W1896620427 @default.
• W2938688055 cites W1965551643 @default.
• W2938688055 cites W1965849267 @default.
• W2938688055 cites W1968384310 @default.
• W2938688055 cites W1978400994 @default.
• W2938688055 cites W1980147374 @default.
• W2938688055 cites W1980429463 @default.
• W2938688055 cites W1995603223 @default.
• W2938688055 cites W2001944176 @default.
• W2938688055 cites W2005089506 @default.
• W2938688055 cites W2005238966 @default.
• W2938688055 cites W2005670875 @default.
• W2938688055 cites W2008969642 @default.
• W2938688055 cites W2010528106 @default.
• W2938688055 cites W2015087990 @default.
• W2938688055 cites W2036954663 @default.
• W2938688055 cites W2063654600 @default.
• W2938688055 cites W2067797623 @default.
• W2938688055 cites W2068187932 @default.
• W2938688055 cites W2068476516 @default.
• W2938688055 cites W2071602154 @default.
• W2938688055 cites W2095127030 @default.
• W2938688055 cites W2103657327 @default.
• W2938688055 cites W2111151349 @default.
• W2938688055 cites W2114987094 @default.
• W2938688055 cites W2117923917 @default.
• W2938688055 cites W2120785361 @default.
• W2938688055 cites W2121880087 @default.
• W2938688055 cites W2150193843 @default.
• W2938688055 cites W2153058089 @default.
• W2938688055 cites W2154270856 @default.
• W2938688055 cites W2414136284 @default.
• W2938688055 cites W2473250294 @default.
• W2938688055 cites W2607368540 @default.
• W2938688055 cites W4213232857 @default.
• W2938688055 cites W4290728071 @default.
• W2938688055 doi "https://doi.org/10.1259/bjr.20180893" @default.
• W2938688055 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6592087" @default.
• W2938688055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30982331" @default.
• W2938688055 hasPublicationYear "2019" @default.
• W2938688055 type Work @default.
• W2938688055 sameAs 2938688055 @default.
• W2938688055 citedByCount "6" @default.
• W2938688055 countsByYear W29386880552020 @default.
• W2938688055 countsByYear W29386880552021 @default.
• W2938688055 countsByYear W29386880552022 @default.
• W2938688055 countsByYear W29386880552023 @default.
• W2938688055 crossrefType "journal-article" @default.
• W2938688055 hasAuthorship W2938688055A5001639498 @default.
• W2938688055 hasAuthorship W2938688055A5045497498 @default.
• W2938688055 hasAuthorship W2938688055A5048847703 @default.
• W2938688055 hasAuthorship W2938688055A5076118084 @default.
• W2938688055 hasAuthorship W2938688055A5091357479 @default.
• W2938688055 hasBestOaLocation W29386880552 @default.
• W2938688055 hasConcept C120665830 @default.
• W2938688055 hasConcept C121332964 @default.
• W2938688055 hasConcept C126322002 @default.
• W2938688055 hasConcept C126838900 @default.
• W2938688055 hasConcept C141071460 @default.
• W2938688055 hasConcept C144024400 @default.
• W2938688055 hasConcept C149923435 @default.
• W2938688055 hasConcept C167135981 @default.
• W2938688055 hasConcept C2775901891 @default.
• W2938688055 hasConcept C2776098176 @default.
• W2938688055 hasConcept C2777628954 @default.
• W2938688055 hasConcept C2777849778 @default.
• W2938688055 hasConcept C2780084366 @default.
• W2938688055 hasConcept C2780643987 @default.
• W2938688055 hasConcept C2780868729 @default.
• W2938688055 hasConcept C61511704 @default.
• W2938688055 hasConcept C71924100 @default.
• W2938688055 hasConceptScore W2938688055C120665830 @default.
• W2938688055 hasConceptScore W2938688055C121332964 @default.
• W2938688055 hasConceptScore W2938688055C126322002 @default.
• W2938688055 hasConceptScore W2938688055C126838900 @default.
• W2938688055 hasConceptScore W2938688055C141071460 @default.
• W2938688055 hasConceptScore W2938688055C144024400 @default.
• W2938688055 hasConceptScore W2938688055C149923435 @default.
• W2938688055 hasConceptScore W2938688055C167135981 @default.
• W2938688055 hasConceptScore W2938688055C2775901891 @default.
• W2938688055 hasConceptScore W2938688055C2776098176 @default.
• W2938688055 hasConceptScore W2938688055C2777628954 @default.
• W2938688055 hasConceptScore W2938688055C2777849778 @default.
• W2938688055 hasConceptScore W2938688055C2780084366 @default.
• W2938688055 hasConceptScore W2938688055C2780643987 @default.

• next